TMS Research Studies
A multi-center, longitudinal, naturalistic, observational research study reported at the American Psychiatric Association’s 2013 Annual Meeting, showed that acute TMS induced “statistically and clinically meaningful response and remission” in patients with treatment-resistant major depressive disorder (TR-MDD) during the acute phase, and that the results were maintained at 52 weeks.
“This is the first study to examine 12-month outcomes of TMS in a large dataset in a real-life setting. We have data on 257 patients that got all the way through the long-term follow-up, and we found that 68% improved and 45% had complete remission at 1 year follow-up,” reported Linda L. Carpenter, MD, study investigator and professor, at the Department of Psychiatry and Human Behavior, Brown University School of Medicine, and chief, Mood Disorders Program, Butler Hospital, in Providence, Rhode Island, as she told Medscape Medical News.
Additional Facts about NeuroStar TMS Depression Treatment
Patients Undergoing TMS Treatment are:
- Awake and alert during treatment
- Able to return to their normal activities immediately after treatment
- In the office for treatment which takes approximately 40 minutes
- Coming for treatment 5 days a week, for approximately 4 to 6 weeks
To learn more about TMS Treatment or to set up an appointment to see if TMS treatment is right for you-call Psychiatrist Daniela White, M.D. at 713-426-3100.
Check out our Television Interview Video on TMS
TMS for Resistant Depression: Long-term Results Are In
See a list of publications by Mayo doctors on transcranial magnetic stimulation on PubMed, a service of the National Library of Medicine.